Source - SMW
Mercia Technologies has completed a £500,000 investment into Oxford Genetics, a synthetic biology company with significant expertise in DNA design. 

This investment follows the £1.0m of additional capital which was provided by Mercia in October 2016 in order to expand the company's management team, board, patent portfolio and commercialisation strategy.




At 8:58am: (LON:MERC) Mercia Technologies Plc share price was 0p at 34.5p